Illumina Aktie

119,75USD -13,80USD -10,33%
Illumina für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 927079 / ISIN: US4523271090

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 9 800 11 500 12 010 10 370 0
Umsatz pro Mitarbeiter in Mio. EUR 0,46 0,40 0,38 0,42 0,00

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 2 713 3 561 2 609 2 746 3 289
Summe Anlagevermögen 12 504 8 691 7 502 3 557 3 355
Summe Aktiva 15 217 12 252 10 111 6 303 6 644

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 4 477 5 653 4 366 3 930 3 921
Summe Eigenkapital 10 740 6 599 5 745 2 373 2 723
Summe Passiva 15 217 12 252 10 111 6 303 6 644

Adresse

5200 Illumina Way, 92122 San Diego
Telefon +1 (858) 202-4500
Fax +1 (858) 202-4545
Internet http://www.illumina.com

Management

Ankur Dhingra
Chief Financial Officer
Anna S. Richo
Independent Director
Bas Verhoef
Head-Europe Region
Bryan Crane
Vice President & Head-System Design
Caroline D. Dorsa
Independent Director
Eric Green
Chief Medical Officer
Frances Hamilton Arnold
Independent Director
Gary S. Guthart
Independent Director
Jacob Thaysen
Chief Executive Officer & Director
Jakob Wedel
Chief Strategy & Corporate Development Officer
Keith Arlyn Meister
Independent Director
Kevin Pegels
Chief-Global Operations
Pat Leckman
Chief People Officer
Philip W. Schiller
Independent Director
Robert S. Epstein
Independent Director
Scott B. Ullem
Independent Director
Scott Davies
Secretary, Chief Legal Officer & General Counsel
Scott Ericksen
Chief Accounting Officer & Vice President
Scott Gottlieb
Non-Executive Chairman
Steven Barnard
Chief Technology Officer
Susan E. Siegel
Independent Director